Skip to main content
SpringerLink
Log in
Book cover

Kompendium Internistische Onkologie pp 901–939Cite as

Metastasen bei unbekanntem Primärtumor — „CUP-Syndrom“

  • Chapter

Zusammenfassung

Patienten mit Metastasen von unbekannten Primärtumoren sind ein diagnostisches und therapeutisches Problem; ihr Anteil am Patientenkollektiv onkologischer Zentren beträgt 5% bis 10% [30, 41, 19]. „Metastasen bei unbekanntem Primärtumor“ sollten als eigenständiges Syndrom gekennzeichnet werden, da es sich in der Regel um eine besonders maligne biologische Ausdrucksform des — unbekannten -Primärtumors handelt und entsprechende spezifische diagnostische und therapeutische Vorgehensweisen erfordert. Dieses Syndrom wird im folgenden als „CUP-Syndrom“ (Carcinom mit unbekanntem Primärtumor; Carcinoma of Unknown Primary) bezeichnet [30, 28]; ein übliches Synonym ist „Metastasen bei unbekanntem Primärtumor“ (Metastases of Unknown Origin; „MUO“).

This is a preview of subscription content, log in via an institution.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Altmannsberger M, Broese M (1984): Immunzytologische Klassifizierung von Metastasen bei unbekanntem Primärtumor. Verh Dtsch Ges Path 68:486

    Google Scholar 

  2. Batsakis JG (1981): The pathology of head and neck tumors. The occult primary and metastases to head and neck, part 10. Head Neck Surg 3:409–423

    Article  PubMed  CAS  Google Scholar 

  3. Didolkar S, Fanous N, Elias EG, et al (1977): Metastatic carcinomas of occult primary tumors. A study of 254 cases. Ann Surg 186:625–630

    CAS  Google Scholar 

  4. Fer MF, Sherwin SA, Oldham RK, Greco FA, Matthews MJ (1982): Poorly differentiated Lung Cancer. Semin Oncol 9:456–466

    PubMed  CAS  Google Scholar 

  5. Fer MF, Levenson RM, Cohen MH et al (1981): Extrapulmonary small cell carcinoma. In: Greco FA, Oldham RK, Bunn PA (eds) Small Cell Lung Cancer, Grune and Stratton New York, pp301–325

    Google Scholar 

  6. Feverman L, Attie JN, Rosenberg B (1962): Carcinoma in axillary lymph nodes. Surg Gynecol Obstet 114: 5 ff

    Google Scholar 

  7. Friedmann W, Steffens J, Lobeck H et al (1984): Immunhistochemische Charakterisierung von Metastasen des Prostatakarzinoms. Verh Dtsch Ges Path 68:115–117

    Google Scholar 

  8. Gatter KC, Mason DY (1982): The Use of Monoclonal Antibodies for Histopathologic Diagnosis of Human Malignancy. Semin Oncol 9:517–525

    PubMed  CAS  Google Scholar 

  9. Gilbert HA, Kagan AR (1976): Metastases: Incidence, detection and evaluation without histologic confirmation. In: Weiss L (ed): Fundamental Aspects of Metastasis. New York, American Elsevier, pp 383–405

    Google Scholar 

  10. Giuliano AE, Alistair JC, Morton DL (1982): Melanoma from unknwon primary site and amelanotic melanoma. Semin Oncol 9:442–447

    PubMed  CAS  Google Scholar 

  11. Goldberg R, Smith F, Meno W et al (1986): Treatment of Adenocarcinoma of unknown primary with Fluorouracil, Adriamycin and Mitomycin C (FAM). Proc Am Soc Clin Oncol 5:129

    Google Scholar 

  12. Goldberg RM, Smith FP et al (1986): 5-Fluorouracil. Adriamycin, and Mitomycin in the Treatment of Adenocarcinoma of unknown Primary. J Clin Oncol 4: 395–399

    PubMed  CAS  Google Scholar 

  13. Greco FA, Oldham RK, Fer FM (1982): The extragonadal Germ Cell Cancer Syndrome. Semin Oncol 9:448–455

    PubMed  CAS  Google Scholar 

  14. Greenberg BR, Salom SE (1984): Human Tumor Clonogenic Assay in Patients with unknown Primary Carcinoma. J Clin Oncol 2:46–50

    PubMed  CAS  Google Scholar 

  15. Hausher FH, Jarbro JW (1985): Diagnosis and Treatment of Malignant Pleural Effusion. Semin Oncol Vol 12:54–75

    Google Scholar 

  16. Johnson RO, Castro R, Ansfield R (1964): Response of primary unknown cancers to treatment with 5-Fluorouracil. Cancer Chemotherapy Rep 38:63–64

    CAS  Google Scholar 

  17. Jordan WE, Shildt RA (1985): Adenocarcinoma of unknown Primary Site. The Brooke Army Medical Center Experience. Cancer 55:857–860

    Google Scholar 

  18. Jundt G, Schulz A, Paul E et al (1984): S-100-Protein in amelanotischen malignen Melanomen. Verh Dtsch Ges Path 68:526

    Google Scholar 

  19. Kambhu S, Kelsen D, et al (1986): Phase II trial of mitomycin C (M), Vindesine (D) and Adriamycin (A) and predictive variables in the treatment of patients (pts) with adenocarcinoma of unknown primary site (ACUP). Proc Am Assoc Cancer Res 27:185

    Google Scholar 

  20. Kehl A (1984): Bedeutung der Punktionszytologie für den Nachweis von Metastasen bei bekanntem oder unbekanntem Primärtumor aus der Sicht des Onkologen. Verh Dtsch Ges Path 68:479–480

    Google Scholar 

  21. Krementz ET, Cerise EJ, Ciaravella JM, et al (1977): Metastases of undetermined source. Cancer 27:289–300

    CAS  Google Scholar 

  22. Lainswoth JD, Greco FA (1986): Clinical characteristics of patients with advanced poorly differentiated carcinoma (PDG) and adenocarcinoma (PDA) of unknown primary who achieved complete response (CR) to combination chemotherapy. Proc Am Soc Clin Oncol 5:127

    Google Scholar 

  23. Le Chavalier Th, Smith FP et al (1985): Sites of primary malignancies in patients presenting with cerebral metastases. Cancer 56:880–882

    Article  Google Scholar 

  24. Le Chevalier T, Caille P et al (1985): Carcinoma of unknown primary. A study of 302 consecutive autopsied patients. Proc Am Soc Clin Oncol 4:8

    Google Scholar 

  25. Mackay B, Ordonez NG (1982): The Role of the Pathologist in the Evaluation of Poorly Differentiated Tumors. Semin Oncol 9:396–418

    PubMed  CAS  Google Scholar 

  26. McGovern NJ (1975): Spontaneous regression of melanoma. Pathology 7:91–99

    Article  PubMed  CAS  Google Scholar 

  27. Metz K, Richter HJ, Leder LD (1984): Immunhistochemische Befunde an großzelligen Lymphomen. Verh Dtsch Ges Path 68:448

    Google Scholar 

  28. Meyer JS (1982): Potential Value of Cell Kinetics in Management of Cancers of unknown origin. Semin Oncol 9:513–516

    PubMed  CAS  Google Scholar 

  29. Mikuz G (1984): Retroperitoneale Lymphknotenmetastasen. Verh Dtsch Ges Path 68:485

    Google Scholar 

  30. Moertel CG, Reitermeier RJ, Schutt AJ, et al (1972): Treatment of the patient with adenocarcinoma of unknown origin. Cancer 30:1469–1472

    Article  PubMed  CAS  Google Scholar 

  31. Müller HA (1984): Lymphknotenmetastasen in der Kopf-Hals-Region. Verh Dtsch Ges Path 68:481

    Google Scholar 

  32. Neumann KH, Nystrom JS (1982): Metastatic Cancer of unknown origin: Nonsquamous Cell Type. Semin Oncol 9:427–434

    PubMed  CAS  Google Scholar 

  33. Nystrom JS, Weiner JM et al (1979): Identifying the primary site in metastatic cancer of unknown origin. JAMA 241:381–383

    Article  PubMed  CAS  Google Scholar 

  34. Osteen RT, Kopf G, Wilson R (1978): In pursuit of the unknown primary. Am J Surg 135:494–497

    Article  PubMed  CAS  Google Scholar 

  35. Pasterz R, et al (1985): Analysis of prognostic factors in patients with metastatic carcinoma of unknown primary. Proc ASCO 4:151

    Google Scholar 

  36. Pfützer P (194): Nachweis von Metastasen in Ergüssen der Körperhöhlen. Verh Dtsch Ges Path 68: 482

    Google Scholar 

  37. Richardson RL, Weiland LH (1982): Undifferentiated small cell carcinomas in extrapulmonary sites. Semin Oncol 9:484–496

    PubMed  CAS  Google Scholar 

  38. Robert NJ, Garnick MB, Frei E (1982): Cancers of unknown origin, Current Approaches and Future Perspectives. Semin Oncol 9:526–531

    PubMed  CAS  Google Scholar 

  39. Ruddon RW (1982): Tumor markers in the Recognition and Management of Poorly Differentiated Neoplasms and Cancers of unknown primary. Semin Oncol 9:416–426

    PubMed  CAS  Google Scholar 

  40. Schaffer R, Müller HA, Osmanns U (1984): Immunzytochemische Befunde in Ausstrichpräparaten aus der Schilddrüse. Verh Dtsch Ges Path 68:497

    Google Scholar 

  41. Schrink-Moormann P, Schwerk U (1984): Lebermetastasen (Zytohisto-logische Untersuchungen). Verh Dtsch Ges Path 68:483

    Google Scholar 

  42. Schwarze EW (1983): Differentialdiagnose der malignen Lymphome unter besonderer Berücksichtigung der Non-Hodgkin-Lymphome. Diagnostik 16:32–34

    Google Scholar 

  43. Shildt RA, Kennedy PS et al (1983): Management of patients with metastatic adenocarcinoma of unknown origin: A Southwest oncology Group study. Cancer Treat Rep. 67:77–79

    PubMed  CAS  Google Scholar 

  44. Silverman C, Marks JE (1982): Metastatic Cancer of unknown origin: Epidermoid and Undifferentiated Carcinoma. Semin Oncol 9:435–441

    PubMed  CAS  Google Scholar 

  45. Sprenger E (1984): Risiko der Metastasierung bei Feinnadelpunktionen. Verh Dtsch Ges Path 68:487

    Google Scholar 

  46. Staub E, Jungi WF, Gloar F, Senn HJ (1981): Lymphknotenmetastasen bei unbekanntem Primärtumor: Sinn und Unsinn einer breiten Abklärung. Schweiz med Wschr 111:1298–1300

    PubMed  CAS  Google Scholar 

  47. Heyden v. HW, Hansen D, Kaboth GA, Hoffmann H, Schneider (1984): Metastasierendes Adenokarzinom bei unbekanntem Primärtumor. Dtsch med Wschr 109:15–19

    Article  Google Scholar 

  48. Walach U (1986): Treatment of adenocarcinoma of unknown origin with cylophosphamide (C), Oncovin (O), Methotrexate (M) and 5-Fluorouracil (F) (COMF). Proc Am Soc Clin Oncol 5:125

    Google Scholar 

  49. Woods RL, Fox RM, et al (1980): Metastatic adenocarcinomas of unknown primary site. N Engl J Med 303:87–89

    Article  PubMed  CAS  Google Scholar 

  50. York JC, Glick AD, Collins RD (1982): Unclassified Leukemias and Lymphomas. Semin Oncol 9:497–503

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. I. Wildfang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H.-J. Schmoll
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 1987 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Wildfang, I., Schmoll, HJ. (1987). Metastasen bei unbekanntem Primärtumor — „CUP-Syndrom“. In: Kompendium Internistische Onkologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-96893-8_2

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-96893-8_2

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-15380-1

  • Online ISBN: 978-3-642-96893-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation